Scarica l'app Stockscreener
15.07
0.20%
0.03
Dopo l'orario di chiusura:
15.05
-0.02
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$15.04
Aprire:
$15.4
Volume 24 ore:
1.98M
Relative Volume:
0.79
Capitalizzazione di mercato:
$2.27B
Reddito:
$5.82B
Utile/perdita netta:
$-411.00M
Rapporto P/E:
-5.5082
EPS:
-2.7359
Flusso di cassa netto:
$154.00M
1 W Prestazione:
-2.65%
1M Prestazione:
+3.29%
6M Prestazione:
-15.34%
1 anno Prestazione:
-7.43%
Intervallo 1D:
$15.01
$15.45
Intervallo di 1 settimana:
$15.01
$15.62
Portata 52W:
$10.44
$28.67
Citigroup Inc Stock (CC) Company Profile
Nome
Citigroup Inc
Settore
Industria
Telefono
302 773 1000
Indirizzo
1007 MARKET STREET, WILMINGTON, DE
Compare CC vs JPM, BAC, HSBC, RY, WFC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CC
Citigroup Inc
|
15.07 | 2.26B | 5.82B | -411.00M | 154.00M | -2.7359 |
JPM
Jpmorgan Chase Co
|
353.56 | 942.89B | 297.42B | 64.78B | 148.32B | 23.34 |
BAC
Bank Of America Corp
|
62.56 | 438.24B | 194.43B | 33.77B | 64.54B | 4.3483 |
HSBC
Hsbc Holdings Plc Adr
|
103.70 | 359.98B | 133.80B | 21.76B | 105.99B | 6.0511 |
RY
Royal Bank Of Canada
|
205.98 | 286.31B | 99.69B | 16.04B | 26.84B | 11.15 |
WFC
Wells Fargo Co
|
89.45 | 271.16B | 128.92B | 22.97B | -2.35B | 6.8796 |
Citigroup Inc Stock (CC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-27 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-01-28 | Iniziato | Truist | Buy |
| 2024-07-09 | Aggiornamento | UBS | Neutral → Buy |
| 2024-06-07 | Iniziato | Mizuho | Neutral |
| 2024-04-09 | Aggiornamento | BMO Capital Markets | Underperform → Outperform |
| 2024-03-05 | Downgrade | UBS | Buy → Neutral |
| 2024-02-29 | Downgrade | BMO Capital Markets | Outperform → Underperform |
| 2023-12-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-06-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-01-24 | Aggiornamento | UBS | Neutral → Buy |
| 2023-01-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-01-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-01 | Iniziato | Credit Suisse | Underperform |
| 2022-10-13 | Iniziato | Goldman | Neutral |
| 2022-10-05 | Downgrade | Argus | Buy → Hold |
| 2022-06-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-06-10 | Iniziato | Wolfe Research | Outperform |
| 2021-06-09 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-05-20 | Iniziato | BofA Securities | Buy |
| 2021-05-06 | Aggiornamento | Argus | Hold → Buy |
| 2021-01-08 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-12-04 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-11-30 | Iniziato | Alembic Global Advisors | Overweight |
| 2020-03-23 | Downgrade | Jefferies | Buy → Hold |
| 2020-02-14 | Aggiornamento | CFRA | Buy → Strong Buy |
| 2019-11-06 | Aggiornamento | CFRA | Hold → Buy |
| 2019-08-20 | Aggiornamento | Susquehanna | Neutral → Positive |
| 2019-08-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-08-06 | Downgrade | Argus | Buy → Hold |
| 2019-08-05 | Downgrade | SunTrust | Buy → Hold |
| 2019-07-12 | Downgrade | Citigroup | Buy → Neutral |
| 2019-05-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-04-15 | Aggiornamento | SunTrust | Hold → Buy |
| 2019-02-19 | Downgrade | Susquehanna | Positive → Neutral |
| 2019-01-08 | Iniziato | HSBC Securities | Buy |
| 2019-01-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-11-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-07-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-01-30 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-12-06 | Downgrade | Goldman | Buy → Neutral |
| 2017-08-07 | Aggiornamento | UBS | Sell → Neutral |
Mostra tutto
Citigroup Inc Borsa (CC) Ultime notizie
Citigroup (C) Completed a Weekend Tokenized-Dollar Transfer. Can the Network Scale? - Yahoo Finance
SIG Maintained by Citigroup -- Price Target Raised to $140 - GuruFocus
Sana Biotechnology at citigroup’s biopharma back to school summit 2026: diabetes push - Investing.com
BioMarin at Citi summit: voxzogo drives growth as pipeline widens By Investing.com - Investing.com Canada
SYK Maintained by Citigroup -- Price Target Lowered to $360 - GuruFocus
Transcript : Novavax, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 10 - marketscreener.com
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc. - StreetInsider
Kymera Therapeutics at citigroup summit: oral immunology push gains pace By Investing.com - Investing.com India
SpyGlass Pharma at Citigroup summit: glaucoma lens nears phase iii By Investing.com - Investing.com Canada
SAB BIO at Citi summit: trial progress and a bigger t1d bet - Investing.com India
Jazz Pharmaceuticals at citigroup summit: rare-disease push gains pace By Investing.com - Investing.com India
Roivant at Citi summit: cash-rich biotech leans on three pillars - Investing.com Canada
MercadoLibre Secures $1.0 Billion 5.850% Notes Due 2036 With BofA, Citi, Goldman and Others - TradingView
Form 424B2 CITIGROUP INC - StreetInsider
Acumen at Citi biopharma summit: bets on oligomers and brain delivery - Investing.com
C Pushes Tokenized Deposits Deeper Into Asia With Japan Expansion - TradingView
Citigroup Inc. stock gains as recent earnings beat expectations - ad-hoc-news.de
Why Is Citigroup (NYES:C) Expanding in China Brokerage? - Kalkine Media
Citigroup (C) Gains on Turnaround Momentum - Yahoo Finance
Form 8K Citigroup For: 10 September By Investing.com - Investing.com Canada
Citigroup Adjusts Price Target on Cooper to $60 From $80, Keeps Neutral Rating - marketscreener.com
4 Thriving Investment Bank Behemoths to Buy With Attractive Valuation - TradingView
Citigroup Upgrades UiPath (NYSE:PATH) to "Strong-Buy" - MarketBeat
Nordnet AB And Citigroup Inc. Launch Research Portal Giving Savers Access To Research - marketscreener.com
Citigroup Inc. $C Shares Acquired by Tidal Investments LLC - MarketBeat
Citigroup Adjusts Price Target on Boston Scientific to $57 From $61, Keeps Buy Rating - marketscreener.com
Citigroup Adjusts Price Target on ResMed to $240 From $235, Keeps Neutral Rating - marketscreener.com
Citigroup Inc. $C Position Trimmed by National Pension Service - MarketBeat
WINTON GROUP Ltd Has $11.44 Million Holdings in Citigroup Inc. $C - MarketBeat
Integrated Wealth Concepts LLC Sells 10,009 Shares of Citigroup Inc. $C - MarketBeat
Engineers Gate Manager LP Lowers Stake in Citigroup Inc. $C - MarketBeat
BlueCrest Capital Management Ltd Reduces Holdings in Citigroup Inc. $C - MarketBeat
Citigroup stock heads into the open after a 1.0 percent gain - ad-hoc-news.de
Citigroup Becomes Substantial Shareholder in Lotus Resources with 5.08% Stake - Kalkine
BioAge at Citi biopharma summit: pivot to eye disease and new targets - Investing.com Canada
Citigroup's Private Bank Hires Radzinski From Bank Of America - marketscreener.com
Veradermics at citigroup summit: oral hair-loss drug nears key data - Investing.com
Citi Private Bank hires Radzinski from Bank of America - WTVB
Akamai Technologies Jumps 5.3% After Citigroup Maintains Neutral - AlphaStreet
Transcript : Cytokinetics, Incorporated Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 03:00 PM - marketscreener.com
Beam Therapeutics at Citi summit: platform gains momentum across pipeline By Investing.com - Investing.com Canada
Citigroup : Citi First Quarter, Second Quarter, Third Quarter and Fourth Quarter 2027 Earnings Calls - marketscreener.com
LULU Maintained by Citigroup -- Price Target Lowered to $117.00 - GuruFocus
Cytokinetics at citigroup summit: hcm expansion drives growth hopes By Investing.com - Investing.com India
Cytokinetics at citigroup summit: hcm expansion drives growth hopes - Investing.com
Transcript : Protagonist Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com
Transcript : Beam Therapeutics Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 01 - marketscreener.com
Lexicon Pharmaceuticals at Citi summit: hcm data, t1d reset - Investing.com
Transcript : Spyre Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com
Ollie’s Bargain Outlet Holdings Drops 5.7% After Citigroup Maintains Buy - AlphaStreet
Learn Why The Bull Case For Citi Stock Could Change Following China Brokerage Approval - simplywall.st
Citigroup Inc Azioni (CC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):